$MRK Headlines Novartis divestiture move expec
Post# of 88936
Posted On: 04/26/2014 9:52:37 AM
$MRK Headlines
Novartis divestiture move expected, but with another partner, analyst says 12:52 p.m. April 22, 2014 - blogs.marketwatch.com
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
5 mid-cap stocks that insiders love 12:10 p.m. April 17, 2014 - Insider Monkey
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Merck rises 1.5% to lead Dow gainers 9:33 a.m. April 10, 2014 - William L. Watts
Cisco, Merck, Visa lead Dow gainers 9:32 a.m. April 9, 2014 - William L. Watts
How sector stock funds can make your portfolio whole 7:01 a.m. April 7, 2014 - Jonathan Burton
The market’s rigged, you say? When wasn’t it? 12:03 p.m. April 3, 2014 - David Weidner
3 red-hot investment opportunities 8:40 a.m. April 3, 2014 - Jeff Reeves
Best, worst stocks of the $100 billion club: Morgan Stanley 2:03 p.m. March 31, 2014 - blogs.marketwatch.com
Play-it-safe stock investors may take some risk on jobs 8:30 a.m. March 30, 2014 - Wallace Witkowski
Microsoft, Merck lead early Dow gainers 9:32 a.m. March 28, 2014 - William L. Watts
When it rains, it pours for Nasdaq leadership 12:47 p.m. March 27, 2014 - The Trading Deck
Investors may need to go long if they hope to reap Baxter spinoff rewards 11:40 a.m. March 27, 2014 - blogs.marketwatch.com
Merck, Glaxo delay helping Affordable Care co-pays 4:33 p.m. March 26, 2014 - MarketWatch.com
Germany's Merck to propose 2-for-1 stock split 12:26 p.m. March 26, 2014 - MarketWatch.com
Merck, Cisco lead Dow gainers 9:33 a.m. March 26, 2014 - William L. Watts
3M, Merck lead Dow gainers 9:34 a.m. March 25, 2014 - William L. Watts
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
A tax-friendly alternative to municipal bonds 5:00 a.m. Feb. 27, 2014 - Amit Chopra
5 Dow Stocks Seeing an Outstanding 2014 8:04 a.m. Today - Wall St. Cheat Sheet
Biotech: The Poster Child for Market Volatility in 2014 7:32 a.m. Today - 247WallSt.com
Disappointments? Think Opportunities; Miracle Drug May Be Ailing Gilead: Jim Cramer's Best Blogs 6:00 a.m. Today - TheStreet.com
Is The Vanguard High Dividend Yield ETF Primed For Dividend Growth? 6:04 p.m. April 25, 2014 - Seeking Alpha
Week Ahead: April Jobs Report, FOMC Meeting and Earnings 4:39 p.m. April 25, 2014 - FOXBusiness
Q1 Earnings: A Stronger Weakling than Originally Thought - Earnings Preview 5:32 a.m. April 25, 2014 - Zacks.com
Costly Hepatitis Drugs Vex Prisons 5:23 p.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Merck, P&G and Other Dividend Stocks You Wish You'd Bought in 2013 6:00 a.m. April 24, 2014 - TheStreet.com
Gilead, Illumina Q1 Earnings Win Wall Street's Love 10:39 a.m. April 23, 2014 - Investors Business Daily
Stock Market News for April 23, 2014 - Market News 10:06 a.m. April 23, 2014 - Zacks.com
UBS Top Stocks to Buy Working for Cancer Cures 7:52 a.m. April 23, 2014 - 247WallSt.com
Global Drug Industry Does About-Face 10:12 p.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Drugmakers Prod European Stocks To Post-Easter Rally 5:36 p.m. April 22, 2014 - Investors Business Daily
Novartis, Glaxo Swap Units; Valeant Bids For Allergan 4:50 p.m. April 22, 2014 - Investors Business Daily
Novartis, Glaxo Swap Units; Lilly Buying Animal Biz 10:49 a.m. April 22, 2014 - Investors Business Daily
Stock Market News for April 22, 2014 - Market News 10:06 a.m. April 22, 2014 - Zacks.com
Glaxo Exits Cancer Drugs 8:19 a.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Big Brands to Be United in Joint Venture 5:08 a.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Is Pfizer a Good Portfolio Play? 5:40 p.m. April 21, 2014 - Wall St. Cheat Sheet
Merck & Co Inc (MRK): Today's Featured Health Care Winner 5:00 p.m. April 21, 2014 - TheStreet.com
Schedule for Upcoming Earnings Releases -- Research on Nokia, Boston Scientific, Merck & Co., and Bristol-Myers Squibb 2:09 p.m. April 25, 2014 - PR Newswire - PRF
Andrzej S. Krolewski, MD, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology 12:00 p.m. April 25, 2014 - Marketwire
EMD Serono Presents New Data on Rebif® (interferon beta-1a) and Advancing MS Pipeline at AAN Annual Meeting 9:00 a.m. April 25, 2014 - PR Newswire - PRF
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Chugai Pharma USA Announces Appointment of Chief Medical Officer 2:00 a.m. April 25, 2014 - PR Newswire - PRF
Fitch Affirms Merck & Co.'s Long-term IDR at 'A+'; Outlook Remains Negative 2:24 p.m. April 24, 2014 - BusinessWire - BZX
Global NGO Project HOPE Launches Education Initiative on HPV Infection Prevention in China 9:28 a.m. April 24, 2014 - GlobeNewswire
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Andrzej S. Krolewski, MD, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology 1:13 p.m. April 23, 2014 - Marketwire
Edward S. Horton, MD, Receives American Diabetes Association's Albert Renold Award 1:12 p.m. April 23, 2014 - Marketwire
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth 1:05 p.m. April 23, 2014 - PR Newswire - PRF
Merck and Award-Winning Actress S. Epatha Merkerson Challenge Americans with Type 2 Diabetes to Get to Their Goals 8:00 a.m. April 23, 2014 - PR Newswire - PRF
Oral Hygiene Market in the United Kingdom to 2017: Market Size, Distribution and Brand Share, Key Events and Competitive Landscape 12:45 p.m. April 22, 2014 - PR Newswire - PRF
Merck among NASA Cargo Launching to Space Station 4:15 p.m. April 21, 2014 - PR Newswire - PRF
FDA Approves Merck’s RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults 6:22 p.m. April 17, 2014 - BusinessWire - BZX
Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal 12:37 p.m. April 17, 2014 - PR Newswire - PRF
Brain Cancer Global Clinical Trials Review, H1, 2014 12:25 p.m. April 17, 2014 - PR Newswire - PRF
Physicians Interactive's Transformative Omnio Medical App Expands from iPad to iPhone, Android Versions 7:54 a.m. April 16, 2014 - PR Newswire - PRF
Global Veterinary Vaccines Industry 12:06 p.m. April 15, 2014 - PR Newswire - PRF
Interim Clinical Study Results, Leadership Appointments, and Earnings Release Schedules - Analyst Notes on Merck, Magellan, ABIOMED, CONMED, and Greatbatch 8:00 a.m. April 15, 2014 - PR Newswire - PRF
Novartis divestiture move expected, but with another partner, analyst says 12:52 p.m. April 22, 2014 - blogs.marketwatch.com
GlaxoSmithKline exits cancer drugs 8:36 a.m. April 22, 2014 - MarketWatch.com
5 mid-cap stocks that insiders love 12:10 p.m. April 17, 2014 - Insider Monkey
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Merck rises 1.5% to lead Dow gainers 9:33 a.m. April 10, 2014 - William L. Watts
Cisco, Merck, Visa lead Dow gainers 9:32 a.m. April 9, 2014 - William L. Watts
How sector stock funds can make your portfolio whole 7:01 a.m. April 7, 2014 - Jonathan Burton
The market’s rigged, you say? When wasn’t it? 12:03 p.m. April 3, 2014 - David Weidner
3 red-hot investment opportunities 8:40 a.m. April 3, 2014 - Jeff Reeves
Best, worst stocks of the $100 billion club: Morgan Stanley 2:03 p.m. March 31, 2014 - blogs.marketwatch.com
Play-it-safe stock investors may take some risk on jobs 8:30 a.m. March 30, 2014 - Wallace Witkowski
Microsoft, Merck lead early Dow gainers 9:32 a.m. March 28, 2014 - William L. Watts
When it rains, it pours for Nasdaq leadership 12:47 p.m. March 27, 2014 - The Trading Deck
Investors may need to go long if they hope to reap Baxter spinoff rewards 11:40 a.m. March 27, 2014 - blogs.marketwatch.com
Merck, Glaxo delay helping Affordable Care co-pays 4:33 p.m. March 26, 2014 - MarketWatch.com
Germany's Merck to propose 2-for-1 stock split 12:26 p.m. March 26, 2014 - MarketWatch.com
Merck, Cisco lead Dow gainers 9:33 a.m. March 26, 2014 - William L. Watts
3M, Merck lead Dow gainers 9:34 a.m. March 25, 2014 - William L. Watts
Best stocks for legalized marijuana 1:37 p.m. Feb. 27, 2014 - blogs.marketwatch.com
A tax-friendly alternative to municipal bonds 5:00 a.m. Feb. 27, 2014 - Amit Chopra
5 Dow Stocks Seeing an Outstanding 2014 8:04 a.m. Today - Wall St. Cheat Sheet
Biotech: The Poster Child for Market Volatility in 2014 7:32 a.m. Today - 247WallSt.com
Disappointments? Think Opportunities; Miracle Drug May Be Ailing Gilead: Jim Cramer's Best Blogs 6:00 a.m. Today - TheStreet.com
Is The Vanguard High Dividend Yield ETF Primed For Dividend Growth? 6:04 p.m. April 25, 2014 - Seeking Alpha
Week Ahead: April Jobs Report, FOMC Meeting and Earnings 4:39 p.m. April 25, 2014 - FOXBusiness
Q1 Earnings: A Stronger Weakling than Originally Thought - Earnings Preview 5:32 a.m. April 25, 2014 - Zacks.com
Costly Hepatitis Drugs Vex Prisons 5:23 p.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Merck, P&G and Other Dividend Stocks You Wish You'd Bought in 2013 6:00 a.m. April 24, 2014 - TheStreet.com
Gilead, Illumina Q1 Earnings Win Wall Street's Love 10:39 a.m. April 23, 2014 - Investors Business Daily
Stock Market News for April 23, 2014 - Market News 10:06 a.m. April 23, 2014 - Zacks.com
UBS Top Stocks to Buy Working for Cancer Cures 7:52 a.m. April 23, 2014 - 247WallSt.com
Global Drug Industry Does About-Face 10:12 p.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Drugmakers Prod European Stocks To Post-Easter Rally 5:36 p.m. April 22, 2014 - Investors Business Daily
Novartis, Glaxo Swap Units; Valeant Bids For Allergan 4:50 p.m. April 22, 2014 - Investors Business Daily
Novartis, Glaxo Swap Units; Lilly Buying Animal Biz 10:49 a.m. April 22, 2014 - Investors Business Daily
Stock Market News for April 22, 2014 - Market News 10:06 a.m. April 22, 2014 - Zacks.com
Glaxo Exits Cancer Drugs 8:19 a.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Big Brands to Be United in Joint Venture 5:08 a.m. April 22, 2014 - The Wall Street Journal Interactive Edition
Is Pfizer a Good Portfolio Play? 5:40 p.m. April 21, 2014 - Wall St. Cheat Sheet
Merck & Co Inc (MRK): Today's Featured Health Care Winner 5:00 p.m. April 21, 2014 - TheStreet.com
Schedule for Upcoming Earnings Releases -- Research on Nokia, Boston Scientific, Merck & Co., and Bristol-Myers Squibb 2:09 p.m. April 25, 2014 - PR Newswire - PRF
Andrzej S. Krolewski, MD, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology 12:00 p.m. April 25, 2014 - Marketwire
EMD Serono Presents New Data on Rebif® (interferon beta-1a) and Advancing MS Pipeline at AAN Annual Meeting 9:00 a.m. April 25, 2014 - PR Newswire - PRF
Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Chugai Pharma USA Announces Appointment of Chief Medical Officer 2:00 a.m. April 25, 2014 - PR Newswire - PRF
Fitch Affirms Merck & Co.'s Long-term IDR at 'A+'; Outlook Remains Negative 2:24 p.m. April 24, 2014 - BusinessWire - BZX
Global NGO Project HOPE Launches Education Initiative on HPV Infection Prevention in China 9:28 a.m. April 24, 2014 - GlobeNewswire
Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Andrzej S. Krolewski, MD, PhD, Receives American Diabetes Association's Kelly West Award for Outstanding Achievement in Epidemiology 1:13 p.m. April 23, 2014 - Marketwire
Edward S. Horton, MD, Receives American Diabetes Association's Albert Renold Award 1:12 p.m. April 23, 2014 - Marketwire
HIV Therapeutics in Major Developed Markets to 2019 - Limited Pipeline Efficacy Improvement, Patent Expirations and Stringent Healthcare Spending to Suppress Market Growth 1:05 p.m. April 23, 2014 - PR Newswire - PRF
Merck and Award-Winning Actress S. Epatha Merkerson Challenge Americans with Type 2 Diabetes to Get to Their Goals 8:00 a.m. April 23, 2014 - PR Newswire - PRF
Oral Hygiene Market in the United Kingdom to 2017: Market Size, Distribution and Brand Share, Key Events and Competitive Landscape 12:45 p.m. April 22, 2014 - PR Newswire - PRF
Merck among NASA Cargo Launching to Space Station 4:15 p.m. April 21, 2014 - PR Newswire - PRF
FDA Approves Merck’s RAGWITEK™ (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults 6:22 p.m. April 17, 2014 - BusinessWire - BZX
Merck Serono's President & CEO Belén Garijo has Been Appointed to Board of Directors of L'Oréal 12:37 p.m. April 17, 2014 - PR Newswire - PRF
Brain Cancer Global Clinical Trials Review, H1, 2014 12:25 p.m. April 17, 2014 - PR Newswire - PRF
Physicians Interactive's Transformative Omnio Medical App Expands from iPad to iPhone, Android Versions 7:54 a.m. April 16, 2014 - PR Newswire - PRF
Global Veterinary Vaccines Industry 12:06 p.m. April 15, 2014 - PR Newswire - PRF
Interim Clinical Study Results, Leadership Appointments, and Earnings Release Schedules - Analyst Notes on Merck, Magellan, ABIOMED, CONMED, and Greatbatch 8:00 a.m. April 15, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼